Published in J Invest Dermatol on May 01, 1992
Extracorporeal photopheresis in the treatment of graft-versus-host disease: evidence and opinion. Ther Adv Hematol (2013) 0.93
UVA/UVA1 phototherapy and PUVA photochemotherapy in connective tissue diseases and related disorders: a research based review. BMC Dermatol (2004) 0.93
Extracorporeal photochemotherapy restores Th1/Th2 imbalance in patients with early stage cutaneous T-cell lymphoma. Immunology (1997) 0.92
Extracorporeal photopheresis affects co-stimulatory molecule expression and interleukin-10 production by dendritic cells in graft-versus-host disease patients. Clin Exp Immunol (2008) 0.91
Gilvocarcin V exhibits both equilibrium DNA binding and UV light induced DNA adduct formation which is sequence context dependent. Nucleic Acids Res (1992) 0.90
In vitro treatment of monocytes with 8-methoxypsolaren and ultraviolet A light induces dendritic cells with a tolerogenic phenotype. Clin Exp Immunol (2007) 0.88
Laser in dentistry: An innovative tool in modern dental practice. Natl J Maxillofac Surg (2012) 0.86
Predictors of response to extracorporeal photopheresis in advanced mycosis fungoides and Sézary syndrome. Photodermatol Photoimmunol Photomed (2010) 0.81
Photochemotherapy induces the apoptosis of monocytes without impairing their function. Transplantation (2010) 0.79
Induction of monocyte-to-dendritic cell maturation by extracorporeal photochemotherapy: initiation via direct platelet signaling. Transfus Apher Sci (2013) 0.75
New immunosuppressive drugs in heart transplantation. Curr Control Trials Cardiovasc Med (2001) 0.75
Extracorporeal photopheresis alone and with interferon-alpha2a in chronic hepatitis C patients who failed previous interferon therapy. Dig Dis Sci (1999) 0.75
Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med (1983) 10.09
NIH conference. Acquired immunodeficiency syndrome: epidemiologic, clinical, immunologic, and therapeutic considerations. Ann Intern Med (1984) 6.45
Cytotoxic t cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients. N Engl J Med (1982) 5.72
Inhaled corticosteroid use and bone-mineral density in patients with asthma. Lancet (2000) 5.66
Effects of transforming growth factor beta on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness. J Immunol (1986) 3.29
The pathogenesis of oral lichen planus. Crit Rev Oral Biol Med (2002) 2.78
Death in the AIDS patient: role of cytomegalovirus. N Engl J Med (1983) 2.61
Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome. J Clin Invest (1983) 2.32
Herpesvirus infections in the acquired immune deficiency syndrome. JAMA (1984) 2.25
Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alfa: a 10-year experience at a single institution. J Am Acad Dermatol (1996) 2.03
Comparative virulence and immunogenicity of the Towne strain and a nonattenuated strain of cytomegalovirus. Ann Intern Med (1984) 2.01
Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome. Proc Natl Acad Sci U S A (1996) 1.75
Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells. J Immunol (1987) 1.74
Treatment of intraocular inflammatory disease with cyclosporin A. Lancet (1983) 1.74
Complete molecular remission during biologic response modifier therapy for Sézary syndrome is associated with enhanced helper T type 1 cytokine production and natural killer cell activity. J Am Acad Dermatol (2001) 1.70
HLA-restricted cytotoxic T lymphocyte and nonthymic cytotoxic lymphocyte responses to cytomegalovirus infection of bone marrow transplant recipients. J Immunol (1981) 1.69
The use of calcium hydroxide, antibiotics and biocides as antimicrobial medicaments in endodontics. Aust Dent J (2007) 1.62
Microleakage of composite resin restorations in cervical cavities prepared by Er,Cr:YSGG laser radiation. Aust Dent J (2008) 1.47
IL-12 synthesis by human Langerhans cells. J Immunol (1996) 1.43
HLA-restricted cytotoxic T lymphocytes are an early immune response and important defense mechanism in cytomegalovirus infections. Rev Infect Dis (1984) 1.37
Treatment of cytomegalovirus retinitis with dihydroxy propoxymethyl guanine. Am J Ophthalmol (1986) 1.34
HLA restricted virus-specific cytotoxic T-lymphocyte responses to live and inactivated influenza vaccines. Lancet (1981) 1.28
Aberrant cytokine production by Sezary syndrome patients: cytokine secretion pattern resembles murine Th2 cells. J Invest Dermatol (1992) 1.23
Th2 cytokine mRNA expression in skin in cutaneous T-cell lymphoma. J Invest Dermatol (1994) 1.22
Interferon induction and increased natural killer-cell activity in influenza infections in man. Lancet (1981) 1.21
Adhesion molecule expression in chronic inflammatory periodontal disease tissue. J Periodontal Res (1994) 1.21
The immunopathogenesis of cutaneous T-cell lymphoma. Abnormal cytokine production by Sézary T cells. Arch Dermatol (1993) 1.19
A longitudinal study of Streptococcus mutans colonization in infants after tooth eruption. J Dent Res (2003) 1.18
Chlamydia pneumoniae inhibits apoptosis in human peripheral blood mononuclear cells through induction of IL-10. J Immunol (2000) 1.16
Early cellular events in evolving cutaneous delayed hypersensitivity in humans. Am J Pathol (1991) 1.14
Mast cell/T cell interactions in oral lichen planus. J Oral Pathol Med (2002) 1.14
Selective defects in cytomegalovirus- and mitogen-induced lymphocyte proliferation and interferon release in patients with acquired immunodeficiency syndrome. J Infect Dis (1985) 1.13
Deficient gamma-interferon production in patients with systemic lupus erythematosus. Arthritis Rheum (1986) 1.11
Identification of a novel high molecular weight protein preferentially expressed by sinusoidal endothelial cells in normal human tissues. J Cell Biol (1991) 1.11
Comparison of five selective media for the growth and enumeration of Streptococcus mutans. Aust Dent J (2002) 1.10
Molecular and cell biology of the gingiva. Periodontol 2000 (2000) 1.09
Importance of cytotoxic lymphocytes during cytomegalovirus infection in renal transplant recipients. Am J Med (1984) 1.08
IL-12 reverses cytokine and immune abnormalities in Sezary syndrome. J Immunol (1995) 1.06
Apoptosis induction of ultraviolet light A and photochemotherapy in cutaneous T-cell Lymphoma: relevance to mechanism of therapeutic action. J Invest Dermatol (1996) 1.05
L-tryptophan ingestion associated with eosinophilic fasciitis but not progressive systemic sclerosis. Ann Intern Med (1990) 1.04
Oral colonization of Streptococcus mutans in six-month-old predentate infants. J Dent Res (2001) 1.04
Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanism. J Immunol (1985) 1.01
Mast cell degranulation and the role of T cell RANTES in oral lichen planus. Oral Dis (2001) 1.00
The effect of orthodontic treatment on salivary flow, pH, buffer capacity, and levels of mutans streptococci and lactobacilli. Aust Orthod J (1999) 1.00
Oral lichen planus. Clin Dermatol (2001) 1.00
The in vitro effect of retinol on human gingival epithelium. II. Modulation of Langerhans cell markers and interleukin-1 production. J Invest Dermatol (1985) 1.00
Natural killer cells and interferon responses in patients with systemic lupus erythematosus. Clin Exp Immunol (1982) 0.99
Immunohistological analysis of experimental gingivitis in humans. Clin Exp Immunol (1988) 0.99
Red cell autoantibodies in patients with acquired immune deficiency syndrome. Transfusion (1986) 0.98
Failure to detect human T-lymphotropic virus type-I proviral DNA in cell lines and tissues from patients with cutaneous T-cell lymphoma. J Invest Dermatol (1996) 0.97
Enamel demineralization during orthodontic treatment. Aetiology and prevention. Aust Dent J (1997) 0.97
Extracellular localization of human connective tissue mast cell granule contents. J Invest Dermatol (1991) 0.95
Interferon-related leukocyte inclusions in acquired immune deficiency syndrome: localization in T cells. Am J Clin Pathol (1984) 0.95
Removal of orthodontic bonding resin residues by CO2 laser radiation: surface effects. J Clin Laser Med Surg (1999) 0.94
Is there a role for tumor necrosis factor-alpha (TNF-alpha) in oral lichen planus? J Oral Pathol Med (1996) 0.94
Extracorporeal photochemotherapy does not suppress T- or B-cell responses to novel or recall antigens. J Am Acad Dermatol (1999) 0.93
Matrix metalloproteinases and their inhibitors in oral lichen planus. J Cutan Pathol (2001) 0.93
Overexpression of p53 protein in cutaneous T cell lymphoma: relationship to large cell transformation and disease progression. J Invest Dermatol (1998) 0.92
Orthodontic tooth movement in the prednisolone-treated rat. Angle Orthod (2000) 0.92
Human lymphoblastoid interferon treatment of Kaposi's sarcoma in the acquired immune deficiency syndrome. Clinical response and prognostic parameters. Am J Med (1985) 0.91
Reduced surface expression of transforming growth factor beta receptor type II in mitogen-activated T cells from Sézary patients. Proc Natl Acad Sci U S A (1995) 0.91
Oral health students' perceptions of clinical reflective learning--relevance to their development as evolving professionals. Eur J Dent Educ (2010) 0.90
Use of interleukin-2 in patients with acquired immunodeficiency syndrome. J Biol Response Mod (1984) 0.90
Depressed IL-12-mediated signal transduction in T cells from patients with Sézary syndrome is associated with the absence of IL-12 receptor beta 2 mRNA and highly reduced levels of STAT4. J Immunol (1999) 0.89
Expression of RANTES and CCR1 in oral lichen planus and association with mast cell migration. J Oral Pathol Med (2002) 0.89
Loss of Langerhans cells from gingival tissue maintained in organ culture. J Oral Pathol (1984) 0.89
Prevalence, clinical manifestations, and immunology of herpesvirus infections in the acquired immunodeficiency syndrome. Ann N Y Acad Sci (1984) 0.88
Calcitonin gene-related peptide inhibits proliferation and antigen presentation by human peripheral blood mononuclear cells: effects on B7, interleukin 10, and interleukin 12. J Invest Dermatol (1997) 0.88
A longitudinal study comparing mutans streptococci and lactobacilli colonisation in dentate children aged 6 to 24 months. Caries Res (2012) 0.88
Association of Streptococcus mutans infection and oral developmental nodules in pre-dentate infants. J Dent Res (2001) 0.88
Role of interferon in AIDS. Ann N Y Acad Sci (1984) 0.88
Regulation of cytokine expression in macrophages and the Langerhans cell-like line XS52 by calcitonin gene-related peptide. J Leukoc Biol (1997) 0.88
Laser-activated fluoride treatment of enamel against an artificial caries challenge: comparison of five wavelengths. Aust Dent J (2007) 0.88
Cutaneous necrosis associated with recombinant interferon injection. Report of three cases with interferon beta-1b and review of the literature. Acta Derm Venereol (1997) 0.87
Pulpal heat changes with newly developed resin photopolymerisation systems. Aust Endod J (2002) 0.87
Modulation of gingival Langerhans cell T6 antigen expression in vitro by interleukin 1 and an interleukin 1 inhibitor. Clin Exp Immunol (1986) 0.87
Modulation of class II (DR and DQ) antigen expression on gingival Langerhans cells in vitro by gamma interferon and prostaglandin E2. J Oral Pathol (1986) 0.87
Virus-specific cytotoxic lymphocyte responses are predictive of the outcome of cytomegalovirus infection of renal transplant recipients. Transplant Proc (1984) 0.87
Malignancies in the AIDS patient: natural history, treatment strategies, and preliminary results. Ann N Y Acad Sci (1984) 0.86
Mutans streptococci and lactobacilli colonization in predentate children from the neonatal period to seven months of age. Caries Res (2012) 0.86
The potential therapeutic role of interleukin-12 in cutaneous T-cell lymphoma. Ann N Y Acad Sci (1996) 0.86
Characterization of unmyelinated axons uniting epidermal and dermal immune cells in primate and murine skin. J Cutan Pathol (1998) 0.86
Laser-activated fluoride treatment of enamel as prevention against erosion. Aust Dent J (2007) 0.86
Analysis of workplace injuries in a dental school environment. Aust Dent J (1997) 0.86
Associations between mast cells and laminin in oral lichen planus. J Oral Pathol Med (1998) 0.86
Heat shock protein expression in oral epithelial dysplasia and squamous cell carcinoma. Eur J Cancer B Oral Oncol (1995) 0.86
Immunoglobulin (Gm) markers and alpha 1-antitrypsin (PI) types in rheumatoid arthritis and early onset chronic active hepatitis. J Immunogenet (1984) 0.85
Effect of tooth-related factors on the shear bond strengths obtained with CO2 laser conditioning of enamel. Aust Dent J (1997) 0.85
Heat shock protein expression in oral lichen planus. J Oral Pathol Med (1995) 0.85
Oral mucosal Langerhans cells express DR and DQ antigens. J Dent Res (1986) 0.85
Multi-gene epigenetic silencing of tumor suppressor genes in T-cell lymphoma cells; delayed expression of the p16 protein upon reversal of the silencing. Leuk Res (2005) 0.84
Deficient, HLA-restricted, cytomegalovirus-specific cytotoxic T cells and natural killer cells in patients with the acquired immunodeficiency syndrome. J Infect Dis (1985) 0.84
Allogeneic hematopoietic SCT for primary cutaneous T cell lymphomas. Bone Marrow Transplant (2011) 0.84
Identification of amplified clonal T cell populations in the blood of patients with chronic graft-versus-host disease: positive correlation with response to photopheresis. Bone Marrow Transplant (2002) 0.84